Results 231 to 240 of about 283,736 (263)
Some of the next articles are maybe not open access.
Economics of chronic hepatitis B and hepatitis C
Journal of Hepatology, 2007Although not all patients develop progressive liver disease, chronic hepatitis B and chronic hepatitis C infections cause substantial morbidity and mortality worldwide. To address this need, many new antiviral treatments have become available over the past 10 years.
Arathi, Rajendra, John B, Wong
openaire +2 more sources
Antifibrotics for Chronic Hepatitis C
Clinics in Liver Disease, 2009Development and testing of antifibrotic agents for the treatment of chronic hepatitis C have generally been targeted toward hepatic stellate cells, transforming growth factor-beta, the inflammatory response, or extracellular matrix accumulation. Although several agents such as interferon-gamma, long-term pegylated interferon, and caspase inhibitors ...
openaire +2 more sources
Disease-a-Month, 1994
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
openaire +3 more sources
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
openaire +3 more sources
BMJ clinical evidence, 2018
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source
Treatment of Chronic Hepatitis B and Chronic Hepatitis C
Reviews in Medical Virology, 1996openaire +2 more sources
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Nassim Hammoudi +2 more
exaly
Immune responses and immunopathology in acute and chronic viral hepatitis
Nature Reviews Immunology, 2016Su-Hyung Park +2 more
exaly
Acute Hepatitis A in Patients with Chronic Hepatitis C
Annals of Internal Medicine, 1999B, Helbling +2 more
openaire +2 more sources